ProKidney (PROK) has released an update.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
ProKidney Corp. has moved to motivate and retain key staff by approving a new Supplemental Equity Award for certain employees, including the Chief Legal Officer Todd Girolamo. This award, part of the 2022 Incentive Equity Plan, grants options for employees to buy shares at market value, with a vesting period that begins on March 1, 2025, for half of the shares, followed by monthly installments over the next year.
For further insights into PROK stock, check out TipRanks’ Stock Analysis page.